EX-5.2 6 ny20014590x8_ex5-2.htm EXHIBIT 5.2

Exhibit 5.2

 

  555 Eleventh Street, N.W., Suite 1000
  Washington, D.C.  20004-1304
  Tel: +1.202.637.2200  Fax: +1.202.637.2201
  www.lw.com
     

 

 

 

 

 

 

 

 

 

November 27, 2023

 

Tapestry, Inc.
10 Hudson Yards

New York, NY 10001

FIRM / AFFILIATE OFFICES
Austin Milan
Beijing Munich
Boston New York
Brussels Orange County
Century City Paris
Chicago Riyadh
Dubai San Diego
Düsseldorf San Francisco
Frankfurt Seoul
Hamburg Silicon Valley
Hong Kong Singapore
Houston Tel Aviv
London Tokyo
Los Angeles Washington, D.C.
Madrid  

 

 

Re: Tapestry, Inc. – Registration Statement on Form S-3 (Registration No. 333-253071); USD Notes

 

To the addressee set forth above:

 

We have acted as special counsel to Tapestry, Inc., a Maryland corporation (the “Company”), in connection with the issuance of $4,500,000,000 aggregate principal amount of the Company’s senior unsecured notes, consisting of $500,000,000 aggregate principal amount of its 7.050% Senior Notes due 2025 (the “2025 Notes”), $750,000,000 aggregate principal amount of its 7.000% Senior Notes due 2026 (the “2026 Notes”), $1,000,000,000 aggregate principal amount of its 7.350% Senior Notes due 2028 (the “2028 Notes”), $1,000,000,000 aggregate principal amount of its 7.700% Senior Notes due 2030 (the “2030 Notes”) and $1,250,000,000 aggregate principal amount of its 7.850% Senior Notes due 2033 (the “2033 Notes” and, together with the 2025 Notes, 2026 Notes, the 2028 Notes and the 2030 Notes, the “Notes”), pursuant to a registration statement on Form S-3 under the Securities Act of 1933, as amended (the “Act”), filed with the Securities and Exchange Commission (the “Commission”) on February 12, 2021 (Registration No. 333-253071) (as so filed and as amended, the “Registration Statement”), a base prospectus, dated February 12, 2021, included in the Registration Statement at the time it originally became effective (the “Base Prospectus”), a preliminary prospectus supplement, dated November 15, 2023, filed with the Commission pursuant to Rule 424(b) under the Act, a final prospectus supplement, dated November 15, 2023, filed with the Commission pursuant to Rule 424(b) under the Act on November 17, 2023 (such final prospectus supplement, together with the Base Prospectus, the “Prospectus”), and an underwriting agreement, dated November 15, 2023, among representatives of the several underwriters named in the underwriting agreement and the Company (the “Underwriting Agreement”). The Notes are being issued pursuant to an indenture, dated December 1, 2021 (the “Base Indenture”), between the Company and U.S. Bank Trust Company, National Association (as successor in interest to U.S. Bank National Association), as trustee (the “Trustee”), as supplemented by that certain Second Supplemental Indenture, dated the date hereof, between the Company and the Trustee, setting forth the terms of the Notes (together with the Base Indenture, the “Indenture”). This opinion is being furnished in connection with the requirements of Item 601(b)(5) of Regulation S-K under the Act, and no opinion is expressed herein as to any matter pertaining to the contents of the Registration Statement or related Prospectus, other than as expressly stated herein with respect to the issue of the Notes.

 

 

 

November 27, 2023

Page 2

 

 

As such counsel, we have examined such matters of fact and questions of law as we have considered appropriate for purposes of this letter. With your consent, we have relied upon certificates and other assurances of officers of the Company and others as to factual matters without having independently verified such factual matters. We are opining herein as to the internal laws of the State of New York, and we express no opinion with respect to the applicability thereto, or the effect thereon, of the laws of any other jurisdiction or as to any matters of municipal law or the laws of any local agencies within any state. Various issues concerning Maryland law are addressed in the opinion of Venable LLP, which has been separately provided to you. We express no opinion with respect to those matters herein.

 

Subject to the foregoing and the other matters set forth herein, it is our opinion that, as of the date hereof, when the Notes have been duly executed, issued and authenticated in accordance with the terms of the Indenture and delivered against payment therefor in the circumstances contemplated by the Underwriting Agreement, the Notes will be legally valid and binding obligations of the Company enforceable against the Company in accordance with their respective terms.

 

Our opinions are subject to: (i) the effect of bankruptcy, insolvency, reorganization, preference, fraudulent transfer, moratorium or other similar laws relating to or affecting the rights and remedies of creditors; (ii) (a) the effect of general principles of equity, whether considered in a proceeding in equity or at law (including the possible unavailability of specific performance or injunctive relief), (b) concepts of materiality, reasonableness, good faith and fair dealing and (c) the discretion of the court before which a proceeding is brought; and (iii) the invalidity under certain circumstances under law or court decisions of provisions providing for the indemnification of or contribution to a party with respect to a liability where such indemnification or contribution is contrary to public policy. We express no opinion as to: (a) any provision for liquidated damages, default interest, late charges, monetary penalties, make-whole premiums or other economic remedies to the extent such provisions are deemed to constitute a penalty; (b) consents to, or restrictions upon, governing law, jurisdiction, venue, arbitration, remedies or judicial relief; (c) any provision requiring the payment of attorneys’ fees, where such payment is contrary to law or public policy; (d) any provision permitting, upon acceleration of the Notes, collection of that portion of the stated principal amount thereof that might be determined to constitute unearned interest thereon; and (e) the severability, if invalid, of provisions to the foregoing effect.

 

With your consent, except to the extent we have expressly opined as to such matters with respect to the Company herein, we have assumed (a) that the Indenture and the Notes (collectively, the “Documents”) have been duly authorized, executed and delivered by the parties thereto, (b) that the Documents constitute legally valid and binding obligations of the parties thereto, enforceable against each of them in accordance with their respective terms, and (c) that the status of the Documents as legally valid and binding obligations of the parties is not affected by any (i) breaches of, or defaults under, agreements or instruments, (ii) violations of statutes, rules, regulations or court or governmental orders or (iii) failures to obtain required consents, approvals or authorizations from, or make required registrations, declarations or filings with, governmental authorities.

 

 

 

November 27, 2023

Page 3

 

 

We express no opinion with respect to (i) advance waivers of claims, defenses, rights granted by law or notice, opportunity for hearing, evidentiary requirements, statutes of limitation, trial by jury or at law or other procedural rights; (ii) waivers of broadly or vaguely stated rights; (iii) covenants not to compete; (iv) provisions for exclusivity, election or cumulation of rights or remedies; (v) provisions authorizing or validating conclusive or discretionary determinations; (vi) grants of setoff rights; (vii) proxies, powers and trusts; and (viii) provisions prohibiting, restricting or requiring consent to assignment or transfer of any right or property.

 

This opinion is for your benefit in connection with the Registration Statement and may be relied upon by you and by persons entitled to rely upon it pursuant to the applicable provisions of the Act. We consent to your filing this opinion as an exhibit to the Company’s Form 8-K dated November 27, 2023 and to the reference to our firm contained in the Prospectus under the heading “Legal Matters.” In giving such consent, we do not thereby admit that we are in the category of persons whose consent is required under Section 7 of the Act or the rules and regulations of the Commission thereunder.

 

  Sincerely,
   
  /s/Latham & Watkins LLP